|
Market Closed -
Bombay S.E.
14:02:33 23/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 3,531.70 INR | -2.48% |
|
+3.97% | +218.64% |
Company Valuation: Kwality Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 581.1 | 6,018 | 3,191 | 4,248 | 9,017 | 13,555 |
| Change | - | 935.71% | -46.97% | 33.12% | 112.27% | 50.32% |
| Enterprise Value (EV) 1 | 890.9 | 6,429 | 4,020 | 5,170 | 9,994 | 14,826 |
| Change | - | 621.62% | -37.47% | 28.59% | 93.32% | 48.34% |
| P/E | 3.84x | 5.02x | 16.5x | 17.9x | 22.6x | 20.1x |
| PBR | 0.95x | 3.32x | 1.59x | 1.89x | 3.42x | 4.09x |
| PEG | - | 0x | -0.2x | 0.8x | 0.3x | 0.3x |
| Capitalization / Revenue | 0.22x | 1.31x | 1.27x | 1.38x | 2.44x | 2.69x |
| EV / Revenue | 0.34x | 1.4x | 1.6x | 1.68x | 2.7x | 2.95x |
| EV / EBITDA | 2.95x | 3.71x | 6.52x | 7.6x | 12.2x | 12.3x |
| EV / EBIT | 3.76x | 3.95x | 8.61x | 10.7x | 15.7x | 14.8x |
| EV / FCF | -31x | -28.5x | -15.5x | -39.5x | -155x | -27.5x |
| FCF Yield | -3.22% | -3.51% | -6.43% | -2.53% | -0.64% | -3.64% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 14.6 | 115.6 | 18.67 | 22.93 | 38.4 | 64.9 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 2,631 | 4,579 | 2,510 | 3,072 | 3,702 | 5,031 |
| EBITDA 1 | 301.8 | 1,735 | 616.4 | 680.1 | 820.4 | 1,203 |
| EBIT 1 | 236.9 | 1,628 | 466.8 | 484.5 | 637.5 | 1,005 |
| Net income 1 | 151.5 | 1,200 | 193.7 | 238 | 398.5 | 673.5 |
| Net Debt 1 | 309.8 | 410.6 | 829 | 921.8 | 976.9 | 1,271 |
| Reference price 2 | 56.00 | 580.00 | 307.55 | 409.40 | 869.05 | 1,306.35 |
| Nbr of stocks (in thousands) | 10,376 | 10,376 | 10,376 | 10,376 | 10,376 | 10,376 |
| Announcement Date | 07/09/21 | 07/09/22 | 08/09/23 | 31/08/24 | 18/08/25 | 09/08/26 |
1INR in Million2INR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 386M | ||
| 37.06x | 13.1x | 27.8x | 0.54% | 1,135B | ||
| 38.61x | 6.49x | 18.27x | 2.02% | 635B | ||
| 36.46x | 8.38x | 17.29x | 2.41% | 505B | ||
| 20.87x | 5.11x | 12.73x | 2.56% | 378B | ||
| 105.89x | 5.92x | 25.41x | 2.34% | 358B | ||
| 21.76x | 5.68x | 13.94x | 2.81% | 295B | ||
| 22.43x | 4.53x | 12.94x | 1.95% | 266B | ||
| 27.87x | 7.16x | 12.81x | 2.3% | 237B | ||
| -45.48x | 6.98x | 27.06x | 2.11% | 193B | ||
| Average | 29.50x | 7.04x | 18.69x | 2.12% | 400.4B | |
| Weighted average by Cap. | 35.23x | 8.29x | 20.39x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- KPL Stock
- Valuation Kwality Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















